Korea United Pharmaceutical Incorporated - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Korea United Pharmaceutical Incorporated Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Korea United Pharmaceutical Incorporated. The Company's principal activities are manufacturing and distributing pharmaceuticals. The Company's core offerings include anticancer drugs for cancer of digestive organ, breast and ovary, malignant tumor and myelogenous leukemia; antibiotics for various infection; circulatory drugs used to treat hypertension, stenocardia, diabetes and other disease of circulatory organ; vitamins for weak constitution and vitamin deficiency diseases; antifebrile and anodynes for arthritis, period pains and pain after surgery, and digestive system drugs used to cure gastric ulcer, gastritis, duodenal ulcer and others. The Company is also involved in the research and development of new drugs through its research center in Korea.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report